Eli Lilly pauses trial of its monoclonal antibody to treat coronavirus because of illness

Eli Lilly pauses trial of its monoclonal antibody to treat coronavirus because of illness

Drugmaker Eli Lilly said Tuesday it is pausing its trial of a combination antibody treatment for coronavirus for safety reasons.

Related